#METABOLOMICS WORKBENCH araskind_20150413_9550621_mwtab.txt DATATRACK_ID:233 STUDY_ID:ST000170 ANALYSIS_ID:AN000447 PROJECT_ID:PR000223
VERSION             	1
CREATED_ON          	2016-09-17
#PROJECT
PR:PROJECT_TITLE                 	Leukemia stem cells studies_dup
PR:PROJECT_TYPE                  	Glycolysis/TCA/Nucleotide analysis (tissue/cells)
PR:PROJECT_SUMMARY               	Define the function of AMPK metabolic sensor in leukemia stem cells
PR:INSTITUTE                     	Baylor College of Medicine
PR:DEPARTMENT                    	Molecular and Human genetics
PR:LABORATORY                    	Nakada Lab
PR:LAST_NAME                     	Nakada
PR:FIRST_NAME                    	Daisuke
PR:ADDRESS                       	Houston, TX
PR:EMAIL                         	nakada@bcm.edu
PR:PHONE                         	713-798-1175
#STUDY
ST:STUDY_TITLE                   	13C mass isotopomer analysis (LCMS flux studies) MLL-AF9 (part III)
ST:STUDY_TYPE                    	Glycolysis/TCA/Nucleotide analysis (tissue/cells)
ST:STUDY_SUMMARY                 	How cancer cells adapt to metabolically adverse conditions in patients and
ST:STUDY_SUMMARY                 	to proliferate is a fundamental question in cancer biology. Here we show that
ST:STUDY_SUMMARY                 	protein kinase (AMPK), a metabolic checkpoint kinase, confers metabolic stress
ST:STUDY_SUMMARY                 	to leukemia-initiating cells (LICs) and promotes leukemogenesis. Upon dietary
ST:STUDY_SUMMARY                 	MLL-AF9-induced murine acute myeloid leukemia (AML) activated AMPK and
ST:STUDY_SUMMARY                 	leukemogenic potential. AMPK deletion significantly delayed leukemogenesis and
ST:STUDY_SUMMARY                 	LICs by reducing the expression of glucose transporter 1 (Glut1), compromising
ST:STUDY_SUMMARY                 	flux, and increasing oxidative stress and DNA damage. LICs were particularly
ST:STUDY_SUMMARY                 	on AMPK to suppress oxidative stress in the hypoglycemic bone marrow
ST:STUDY_SUMMARY                 	Strikingly, AMPK inhibition synergized with physiological metabolic stress
ST:STUDY_SUMMARY                 	by dietary restriction and profoundly suppressed leukemogenesis. Our results
ST:STUDY_SUMMARY                 	that AMPK protects LICs from metabolic stress and that combining AMPK
ST:STUDY_SUMMARY                 	with physiological metabolic stress potently suppresses AML by inducing
ST:STUDY_SUMMARY                 	stress and DNA damage.
ST:INSTITUTE                     	University of Michigan
ST:DEPARTMENT                    	Molecular and Human genetics (Baylor College of Medicine)
ST:LABORATORY                    	Nakada Lab
ST:LAST_NAME                     	Saitoh
ST:FIRST_NAME                    	Yusuke
ST:ADDRESS                       	Houston, TX
ST:EMAIL                         	araskind@med.umich.edu>
ST:PHONE                         	713-798-1175
ST:NUM_GROUPS                    	1
ST:TOTAL_SUBJECTS                	9
#SUBJECT
SU:SUBJECT_TYPE                  	Animal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:SPECIES_GROUP                 	Mammal
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	S00017008	GENOTYPE:AMPKαfl/fl | GROUP:Bone marrow	
SUBJECT_SAMPLE_FACTORS           	-	S00017010	GENOTYPE:AMPKαfl/fl | GROUP:Bone marrow	
SUBJECT_SAMPLE_FACTORS           	-	S00017012	GENOTYPE:AMPKαfl/fl | GROUP:Bone marrow	
SUBJECT_SAMPLE_FACTORS           	-	S00017009	GENOTYPE:AMPKαfl/fl | GROUP:Spleen	
SUBJECT_SAMPLE_FACTORS           	-	S00017011	GENOTYPE:AMPKαfl/fl | GROUP:Spleen	
SUBJECT_SAMPLE_FACTORS           	-	S00017013	GENOTYPE:AMPKαfl/fl | GROUP:Spleen	
SUBJECT_SAMPLE_FACTORS           	-	S00017014	GENOTYPE:AMPKαΔ/Δ | GROUP:Bone marrow	
SUBJECT_SAMPLE_FACTORS           	-	S00017015	GENOTYPE:AMPKαΔ/Δ | GROUP:Bone marrow	
SUBJECT_SAMPLE_FACTORS           	-	S00017016	GENOTYPE:AMPKαΔ/Δ | GROUP:Bone marrow	
#COLLECTION
CO:COLLECTION_SUMMARY            	-
CO:SAMPLE_TYPE                   	Cells
#TREATMENT
TR:TREATMENT_SUMMARY             	-
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	-
SP:SAMPLEPREP_PROTOCOL_FILENAME  	Gly-TCA-nucleotides_analysis_protocol-2015-03-09.docx
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	HILIC
CH:INSTRUMENT_NAME               	Agilent 1260
CH:COLUMN_NAME                   	Phenomenex Luna NH2 (150 x 1mm, 3um)
CH:METHODS_ID                    	AQM020
CH:METHODS_FILENAME              	QTOF-002-HILIC-35min-1mm.m
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:LABORATORY_NAME               	MRC2 (University of Michigan)
AN:ACQUISITION_PARAMETERS_FILE   	QTOF-002-HILIC-35min-1mm.m
AN:PROCESSING_PARAMETERS_FILE    	EX00389-Flux-Quant-method.m
#MS
MS:MS_COMMENTS                   	-
MS:INSTRUMENT_NAME               	Agilent 6520 QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS         	mM
MS_METABOLITE_DATA_START
Samples	S00017008	S00017010	S00017012	S00017009	S00017011	S00017013	S00017014	S00017015	S00017016
Factors	GENOTYPE:AMPKαfl/fl | GROUP:Bone marrow	GENOTYPE:AMPKαfl/fl | GROUP:Bone marrow	GENOTYPE:AMPKαfl/fl | GROUP:Bone marrow	GENOTYPE:AMPKαfl/fl | GROUP:Spleen	GENOTYPE:AMPKαfl/fl | GROUP:Spleen	GENOTYPE:AMPKαfl/fl | GROUP:Spleen	GENOTYPE:AMPKαΔ/Δ | GROUP:Bone marrow	GENOTYPE:AMPKαΔ/Δ | GROUP:Bone marrow	GENOTYPE:AMPKαΔ/Δ | GROUP:Bone marrow
2 or 3-phosphoglycerate	0.2749	0.2178	0.1060	0.0784			0.0791		0.0442
6-Phosphogluconate	0.0355	0.0303	0.0504	0.0209	0.0412	0.0522	0.0721	0.0286	0.0356
Acetyl-CoA	0.0540	0.0442	0.1001	0.0116		0.0125			
Adenosine diphosphate	3.2166	2.9132	3.3073	4.8869	2.6028	3.9940	1.9633	0.6554	1.0599
Adenosine monophosphate	0.9395	0.5836	1.2922	4.9193	5.0201	10.4192	2.8176	1.4996	0.9127
Adenosine triphosphate	1.7826	1.6929	1.6539	2.0781	1.2834	1.3987	1.7462	1.1473	1.2682
Citrate or Isocitrate	1.1254	0.9106	2.5543	0.7856	1.6035	2.7287	1.6892	1.0634	2.4373
Erythrose 4-phosphate	1.2759	0.6095	1.9125	0.5430	1.1120	3.9477	1.6767	1.6723	1.4242
Fructose 1_6-bisphosphate	0.8975	0.7937	6.2013	1.6072	1.5003	10.4554	1.6042	0.5498	0.5502
Malate	4.2773	4.6436	6.8832	3.4428	3.0444	3.1205	2.8250	0.3788	1.9067
Nicotinamide Adenine Dinucleotide oxidized	0.1260	0.0450	0.0191	0.0429	0.0146	0.0113	0.0224	0.0101	0.1229
Nicotinamide Adenine Dinucleotide reduced	9.7775	10.8438	8.3556	9.1727		3.4163	2.8091		2.0664
Phosphoenolpyruvate			0.1169			0.1560			
Ribose-5-phosphate or xylulose 5-phosphate	1.8613	0.9631	1.5465	0.9984	2.3023	2.8097	1.5578	1.2378	2.0549
Sedoheptulose 7-phosphate	0.2601	0.1196	0.4332	0.1314	0.2188	0.5454	0.2105	0.1866	0.1462
Sucrose								0.0019
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	moverz_quant	ri	ri_type	pubchem_id	inchi_key	kegg_id	other_id	other_id_type
2 or 3-phosphoglycerate				724		C00597	2PG/3PG	Nakada_Lab_ID
6-Phosphogluconate				91493		C00345	6PG	Nakada_Lab_ID
Acetyl-CoA				444493		C00024	aCoA	Nakada_Lab_ID
Adenosine diphosphate				6022		C00008	ADP	Nakada_Lab_ID
Adenosine monophosphate				6083		C00020	AMP	Nakada_Lab_ID
Adenosine triphosphate				5957		C00002	ATP	Nakada_Lab_ID
Citrate or Isocitrate				311		C00158	CIT/ICIT	Nakada_Lab_ID
Erythrose 4-phosphate				122357		C00279	E4P	Nakada_Lab_ID
Fructose 1,6-bisphosphate				172313		C00354	FBP	Nakada_Lab_ID
Malate				222656		C00149	MAL	Nakada_Lab_ID
Nicotinamide Adenine Dinucleotide oxidized				10897651		C00003	NAD	Nakada_Lab_ID
Nicotinamide Adenine Dinucleotide reduced				439153		C00004	NADH	Nakada_Lab_ID
Phosphoenolpyruvate				1005		C00074	PEP	Nakada_Lab_ID
Ribose-5-phosphate or xylulose 5-phosphate				77982		C00117	R5P/X5P	Nakada_Lab_ID
Sedoheptulose 7-phosphate				165007		C05382	S7P	Nakada_Lab_ID
Sucrose				5988		C00089	SUC	Nakada_Lab_ID
METABOLITES_END
#END